Objective To investigate distinguishing clinical features that may be useful for etiological diagnosis of hepatic injury, including changes in alanine aminotransferase (ALT) and immunological markers of viral infection. Methods Seventy patients with initial baseline ALT that was greater than 15 times the upper limit of normal (15×ULN) were recruited to the study between January 2011 and December 2011.Hepatic function markers (bilirubin, ALT, prothrombin time, and alkaline phosphatase) were measured by standard biochemical assays and immunological markers of hepatitis virus [hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) and HEV and HBV DNA] were examined by immunoassays and quantitative PCR.Changes in ALT over several weeks were statistically analyzed for correlation with laboratory data. Results Among the inpatient study participants, 74.3% reacted with a single antibody, 5.7% reacted with two kinds of antibodies, and 20.0% reacted with no antibodies.There was no remarkable difference in laboratory data for these groups.However, ALT decreased in a logarithmic-linear manner in conjunction with the development of illness.In HEV-infected patients, the ALT levels decreased more rapidly. Conclusion Immunological markers of viral infection and changes in ALT can facilitate etiological diagnosis of patients with hepatic injury that present with 15 × ULN of ALT.
[1]谈逸云, 申惠国, 黄燕, 等.不同型别急性肝炎临床特征比较[J].中国临床医学, 2008, 15 (3) :374-376.
|
[2]刘万里, 薛茜, 曹明芹, 等.用SPSS实现完全随机设计多组比较秩和检验的多重比较[J].地方病通报, 2007, 22 (2) :27-29.
|
[3]Dufour DR, Lott JA, Nolte FS, et al.Diagnosis and monito-ring of hepatic injury.II.Recommendations for use of labora-tory tests in screening, diagnosis, and monitoring[J].ClinChem, 2000, 46 (12) :2050-2068.
|
[4]张占卿, 董华娟, 黄绍萍, 等.血清丙氨酸氨基转移酶和门冬氨酸氨基转移酶对急性与慢性乙型肝炎的鉴别意义[J].实用肝脏病杂志, 2005, 8 (1) :34-35.
|
[5] 中华医学会肝病学分会, 中华医学会消化病学分会.常用肝脏生物化学试验的临床意义及评价共识[J].中华消化杂志, 2010, 30 (5) :331-340.
|
[6]王娜, 郑英杰, 姜庆五, 等.急性肝炎患者系列血清分型及发病特征研究[J].疾病控制杂志, 2005, 9 (6) :533-537.
|
[7]Rozen P, Korn RJ, Zimmerman HJ.Computer analysis of liv-er function tests and their interrelationship in 347 cases of vi-ral hepatitis[J].Isr J Med Sci, 1970, 6:67-79.
|
[8]王绮夏, 邱德凯, 马雄.2010年美国肝病学会自身免疫性肝炎指南解读[J].中国医学前沿杂志 (电子版) , 2011, 3 (1) :8-13.
|
[9]周鸿良, 陈小静, 杨丽俊, 等.HBc-IgM检测在乙肝鉴别诊断中的意义[J].放射免疫学杂志, 2010, 23 (2) :235-236.
|
[10]夏邦世, 沈忠海, 朱金明, 等.低滴度抗-HBc IgM测定在慢性乙型肝炎病变判断中的价值[J].中华传染病杂志, 2006, 24 (3) :204-205.
|
[11]周镇先, 耿全林.国产抗HBc IgM试剂现况分析[J].临床检验杂志, 2005, 23 (5) :378.
|
[12]孙静媛, 田庚善, 孙凤霞.乙型肝炎患者血清中抗HBc-IgM的临床意义[J].临床肝胆病杂志, 2006, 22 (1) :31-32.
|
[13]张义红, 刘琼, 陈海波, 等.急性乙型肝炎和慢性乙型肝炎病毒感染急性发作临床诊断的鉴别指标[J].中国医药, 2008, 3 (4) :204-205.
|
[14]赵鸿, 田庚善.急性乙型肝炎和慢性乙型肝炎病毒感染急性发作鉴别诊断的临床研究[J].中华实验和临床病毒学杂志, 2004, 18 (4) :363-365.
|
[15]谢雯, 刘庄.病毒性肝炎的临床现状[J].中国临床医生, 2004, 32 (12) :4-6.
|
[16]Lok AS, McMahon BJ.Chronic Hepatitis B:Update 2009.AASLDPractice Guidelines[J].Hepatology, 2009, 50 (3) :661-662.
|
[17]邴桂梅.急性乙型肝炎和慢性乙型肝炎急性发作的比较[J].当代医学, 2011, 17 (16) :96-97.
|
[1] | Hou YiHui, Liu TengFei, Zhao XiaoQing, Zhang LiaoYun. Effect of different direct-acting antivirals on the clinical outcome of genotype 1b chronic hepatitis C and compensated hepatitis C cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 84-87. doi: 10.3969/j.issn.1001-5256.2020.01.019 |
[2] | Zhang JieBing, Guo HongHua. Research advances in hepatitis B cirrhosis with renal injury and the application of antiviral drugs[J]. Journal of Clinical Hepatology, 2019, 35(1): 191-196. doi: 10.3969/j.issn.1001-5256.2019.01.042 |
[3] | Zhang Xi, Li YongGuo. Current status of the application of direct-acting antiviral agents in treatment of chronic hepatitis C and existing problems[J]. Journal of Clinical Hepatology, 2018, 34(4): 853-857. doi: 10.3969/j.issn.1001-5256.2018.04.034 |
[4] | Ren Shan, Chen XinYue. Current research on hepatitis C virus resistance to direct-acting antiviral agents[J]. Journal of Clinical Hepatology, 2015, 31(11): 1807-1812. doi: 10.3969/j.issn.1001-5256.2015.11.010 |
[5] | Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430. |
[6] | Zhang YanMei, Ding XiaoHui. Anti-viral therapy in adult patients with acute hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1327-1330+1344. |
[7] | Guo XinHui, Yan Yan, Li Zhuo, Yin JiMing. Fluorescent reverse transcription-PCR assay for determination of hepatitis C virus genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 65-67. |
[8] | Cheng Ling, Hong GuoHu, Guo Yan, Mao Qing. Prediction of HLA-DRB1*0311/0401 in recognizing epitopes of HCV Core protein of different genotypes[J]. Journal of Clinical Hepatology, 2011, 27(1): 61-64. |
[9] | Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290. |
[10] | Qin Hua, Wu XiaoQing. Distribution and clinical significance of HBV genotypes in Lanzhou district[J]. Journal of Clinical Hepatology, 2010, 26(3): 295-296. |
[11] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[12] | Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394. |
[13] | Chen Yan, Tian DeYing, Xia NingShao. Epidemiology and the genotypes of HEV isolated from patients with hepatitis E in Wuhan[J]. Journal of Clinical Hepatology, 2006, 22(1): 36-38. |
[14] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
[15] | Liu ChengYong, Hou YuanPei, Qian XiuMei, Sun Qing, Song Li. Distribution of hepatitis B virus genotype in Xuzhou and its clinical significance[J]. Journal of Clinical Hepatology, 2005, 21(3): 151-152. |
[16] | Li TingMing, Zhu YouFu, He HaiTang, Mao QianGuo, Wu AiHua, Liang YuFang, Luo KangXian. The relation between chinese hepatitis B virus genotype B C and efficacy of interferon-α.[J]. Journal of Clinical Hepatology, 2005, 21(1): 16-18. |
[18] | Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159. |
[19] | Jiao Jian, Wang JiangBin. Distribution of HCV genotypes and its clinical features in patients coinfected with HCV and HBV[J]. Journal of Clinical Hepatology, 2004, 20(2): 75-76. |
[20] | Yao Gang, Zhang Lian, Bao LiHua. HBV genotypes and efficacy of interferon-α on patients with chronic hepatitis B.[J]. Journal of Clinical Hepatology, 2002, 18(5): 273-274. |